Records containing: Stage IV Breast Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-17I-CURE-1: A Phase II, Single Arm Study of Pembroluzimab Combined With Carboplatin in Patients With Circulating Tumor Cells (CTCs) Positive Her-2 Negative Metastatic Breast Cancer (MBC)
-
CLINICAL_TRIALS study record update · 2026-04-17Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study
-
CLINICAL_TRIALS study record update · 2026-02-17A Phase I Trial of the Safety and Immunogenicity of a Multiple Antigen Vaccine (STEMVAC) in HER2 Negative Advanced Stage Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2026-02-12A Phase I Study of Concurrent Abemaciclib and Radiation Therapy (RT) for Patients With Metastatic Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Breast Cancer
-
CLINICAL_TRIALS study record update · 2026-01-29Window of Opportunity Study Targeting the Inflammatory Milieu of Pregnancy Associated Breast Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-03A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) (HER2 IHC0 or HER2-low [IHC 1+, IHC 2+/ISH-]) Inoperable, Locally Advanced, or Metastatic Breast Cancer and Have Received Endocrine Therapy
-
CLINICAL_TRIALS study record update · 2025-08-13Free-HER: Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-06-26A Single-Arm, Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer: The SAPPHO Study
-
CLINICAL_TRIALS study record update · 2025-05-02Phase I/II Trial of Motesanib in Combination With Ixabepilone and Capecitabine in Women With Locally Recurrent or Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-04-06A Phase I Study of a DNA Plasmid Based Vaccine Encoding the HER-2/Neu Intracellular Domain in Subjects With HER-2/Neu (HER2) Overexpressing Tumors
-
CLINICAL_TRIALS study record update · 2025-01-24St. Judes-Stanford Comprehensive Support Initiative
-
CLINICAL_TRIALS study record update · 2024-12-24Prospective Tissue Collection in Breast Cancer Patients Receiving Preoperative Systemic Therapy
-
CLINICAL_TRIALS study record update · 2024-11-25Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
-
CLINICAL_TRIALS study record update · 2024-10-18Randomized Phase II Trial to Evaluate Alisertib Alone or Combined With Fulvestrant for Women With Advanced, Endocrine-Resistant Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-08-30RCT of Online Mindfulness-Based Stress Reduction for Metastatic Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2024-07-31Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)
-
CLINICAL_TRIALS study record update · 2024-07-23A Phase Ib Trial of BYL719 (an α-Specific PI3K Inhibitor) in Combination With Endocrine Therapy in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-04-11Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide, Taking Into Account the Reparative Cycle of Tumor Cells
-
CLINICAL_TRIALS study record update · 2024-04-08A Pilot Study Using Ultrasound for the Detection of Taxane-Induced Peripheral Neuropathy
-
CLINICAL_TRIALS study record update · 2024-03-07Phase II Trial of Raf Kinase Inhibitor BAY 43-9006 as Single Oral Agent in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane
-
CLINICAL_TRIALS study record update · 2024-03-04Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Patients With Stage Ⅳ Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-11-22A Phase Ib Trial of LY2157299 (TGFβR1 Kinase Inhibitor) With Paclitaxel in Patients With Triple Negative Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-10-23Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
-
CLINICAL_TRIALS study record update · 2023-10-10A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2023-10-05Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based Regimen